Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
11
×
national blog main
national top stories
11
×
boston blog main
life sciences
san francisco blog main
boston top stories
san francisco top stories
texas blog main
texas top stories
biotech
national
new york blog main
new york top stories
san diego blog main
san diego top stories
startups
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
clinical trials
drugs
fda
medical devices
novartis
bristol-myers squibb
cancer immunotherapy
crispr
deals
innovation
investing
What
new
11
×
roundup
bio
drug
cancer
announced
center
companies
drugs
fda
genetic
innovation
ipo
latest
life
medical
medicine
medicines
news
science
texas
today
activity
advance
advantages
aim
approval
approvals
approved
bails
bar
biobridge
biogen
biogen’s
biologic
biology
biopharmaceutical
biotechs
boost
brand
Language
unset
Current search:
new
×
cancer
×
" national top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
JLabs’ Luby Takes the Reins at TMC Innovation Institute in Houston
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
TX Roundup: TMC’s BioBridge to the UK, New Execs at Fannin & TechFW
@xconomy.com
5 years ago
With OneOncology, Flatiron and Cancer Docs Aim to Boost Community Care
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs